Medect Clinical Trials

At Medect/Bragée Clinics, we have extensive experience in conducting clinical research, particularly Phase II and Phase III trials involving investigational treatments and new therapeutic indications.

Over the years, we have participated in approximately twenty international clinical studies, in some cases enrolling more than 100 participants per study. Several of the investigated treatments have subsequently received regulatory approval and are now widely used in clinical practice, including for conditions such as fibromyalgia and chronic back pain.

Our research portfolio extends beyond pain medicine and includes studies in diabetes and other systemic conditions, reflecting our broad clinical expertise and research capacity.

Pharmaceutical companies and research partners frequently approach us to participate in new studies. When relevant, we engage our patient population through newsletters and other communication channels. Many of our patients are highly motivated to participate—both to access new treatment opportunities and to contribute to advancing medical knowledge.

We also maintain well-characterized cohorts and biobanked material, including samples from patients with ME/CFS. Researchers interested in collaboration, joint studies, or access to clinical data and biological samples are warmly invited to contact us. We are particularly interested in partnerships that aim to deepen understanding of post-infectious conditions and accelerate the development of diagnostics and treatments.